NCT01171638

Brief Summary

This is a prospective observational study to determine the reliability and accuracy of Near Infrared Spectroscopy (NIRS) to detect oxygen flow in the extremities of injured and non-injured soldiers over time. This technology may be useful in the detection of acute compartment syndrome. We hypothesize that:

  • NIRS values will be well-correlated with intracompartmental pressure measurements
  • NIRS values will be significantly different between non-injured and injured extremities, and injured extremities treated with fasciotomy for acute compartment syndrome.
  • NIRS values of the upper extremity and feet will correlate to values from normal legs in critical control patients and patients with unilateral sever lower extremity injuries.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2011

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 28, 2010

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 1, 2011

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

June 15, 2011

Status Verified

June 1, 2011

Enrollment Period

1.3 years

First QC Date

July 27, 2010

Last Update Submit

June 14, 2011

Conditions

Keywords

near infrared spectroscopycompartment syndromefasciotomyINVOS

Outcome Measures

Primary Outcomes (1)

  • Incidence of acute compartment syndrome (ACS)

    The "gold standard" criterion for ACS will be "clinical diagnosis". That is, all subjects undergoing fasciotomy for clinically diagnosed ACS (NOT PROPHYLACTIC fasciotomies) will be considered to have ACS. NIRS values will be compared to clinical diagnosis to determine accuracy and threshold values.

    24-48 hours at study site

Secondary Outcomes (1)

  • Intracompartmental pressure (ICP)

    24-48 hours at study site

Study Arms (2)

Critical Controls

Critically injured patients with NO "severe traumatic lower extremity" injuries to provide normative data for the "critically injured" physiological status upon arrival at study site

Device: Near infrared spectroscopy (NIRS)

Investigational cohort

Soldiers with "severe traumatic lower extremity" injuries in "stable" or "critical" physiological status presenting to a participating study site within 12 hours of their injury, to provide data on the acute post-injury phase. This cohort will be made up of: * Patients meeting inclusion criteria for investigational cohort, who have UNILATERAL "severe lower extremity injuries" * Patients meeting inclusion criteria for investigational cohort, who have BILATERAL "severe lower extremity injuries." * Patients meeting inclusion criteria for investigational cohort, who have been clinically diagnosed by the treating provider using that treating providers standards for diagnosing ACS and the patient in addition to be diagnosed with ACS undergoes four-compartment leg fasciotomy.

Device: Near infrared spectroscopy (NIRS)

Interventions

Non-invasive monitoring device applied on the surface of the skin that emits harmless red light to measure tissue perfusion.

Also known as: Equanox Regional Oximeter, Nonin Medical, Plymouth, MN
Critical ControlsInvestigational cohort

Eligibility Criteria

Age15 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critically injured patients (Cohort 1) or patients with severe lower extremity injuries (Cohort 2), admitted to one of the participating sites, who meet the eligibility criteria described below.

You may qualify if:

  • male or female subjects
  • between the ages of 15 and 65 years old
  • (Cohort 1 only) Admitted directly to the ICU of a participating study site
  • (Cohort 2 only) Admitted to a participating study site with the following injury/mechanism combinations:
  • Injuries:
  • Segemental tibia shaft fracture
  • Comminuted tibia shaft fracture
  • Schatzker Type III-VI tibial plateau fractures
  • Mechanisms:
  • Fall from a height of \>= 8 feet
  • Motor vehicle or motorcycle crash
  • Pedestrian versus automobile

You may not qualify if:

  • Patients, in whom application of NIRS monitoring is viewed as an impediment to care.
  • Patients with known prior leg fractures (not related to current injury)
  • History of peripheral vascular disease or lower extremity vascular surgery.
  • Amputation
  • Diagnoses with ACS prior to enrollment
  • Spinal injuries resulting in complete loss of function
  • Mangled lower extremity
  • Bilateral upper extremity injuries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Atlanta Medical Center

Atlanta, Georgia, United States

Location

Grady Memorial Hospital

Atlanta, Georgia, United States

Location

MeSH Terms

Conditions

Compartment Syndromes

Interventions

Spectroscopy, Near-Infrared

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Brett Freedman, MD

    Landstuhl Regional Medical Center

    PRINCIPAL INVESTIGATOR
  • William Reisman, MD

    Emory University

    PRINCIPAL INVESTIGATOR
  • Bruce Ziran, MD

    Atlanta Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ashley Cole

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

July 27, 2010

First Posted

July 28, 2010

Study Start

September 1, 2011

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

June 15, 2011

Record last verified: 2011-06

Locations